In a restrospective review, rituximab appeared beneficial for patients with medication-resistant myasthenia gravis.
Article Limit Reached
You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.
- Award-winning Medical Content
- Latest Advances & Development in Medicine
- Unbiased Content